1 domain / 2 areas / 1 specialization
H.C. Wainwright & Co.
Data updated
H.C. Wainwright & Co., LLC is a New York-based full-service investment bank offering investment banking, equity research, sales and trading, strategic advisory, and corporate access services. The firm says it serves public and private growth companies across multiple sectors and regions, and its office is at 430 Park Avenue, New York, New York 10022.
In the psychedelic ecosystem, H.C. Wainwright matters primarily as a capital-markets and conference platform rather than as a dedicated psychedelic specialist. Its public materials show a strong life sciences and biotechnology orientation, and its events have included companies such as Awakn Life Sciences and Cybin in the broader psychedelics space.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
H.C. Wainwright & Co. is a long-running, New York-based specialty investment bank that focuses on capital markets, equity research, and institutional sales for life sciences and other high-growth sectors. Public materials emphasize its strength in healthcare, biotechnology, and life sciences financing, including placement agent activity in PIPEs, registered directs, and private placements. Its relevance to psychedelics is indirect but meaningful: the firm has hosted and covered companies in the category through investor conferences and capital-markets activity, making it a recurring financial-services counterpart to psychedelic public companies.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 1868
- HQ
- 430 Park Avenue, New York, New York 10022, United States
- Website
- Visit